Leonardo Roever: Non-LDL Biomarkers and The Potential Future Applications for 2ry Stroke Prevention
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Sean Michael Kelly et al, published in Current Atherosclerosis Reports, adding:
”Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
This article reviews the existing literature on non-LDL biomarkers in atherosclerotic cardiovascular disease (ASCVD), atherogenesis, and ischemic stroke risk, including a discussion on potential future applications for secondary stroke prevention.”
Title: Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
Authors: Sean Michael Kelly, Julia Schneider, Michela Rosso, Koto Ishida, Sara Rostanski, Gregory Katz
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 10:32Natalie Arnold: The Lp(a) Puzzle – Why Lower Levels May Not Tell the Whole Story
-
Nov 9, 2026, 10:22ISBT Opens Applications for the I TRY IT Programme 2027
-
Nov 9, 2026, 10:08Ibrahim Mansoor: Rare Tests, Common Diseases – Rethinking Autoimmune Diagnostics
-
Nov 9, 2026, 09:29Veronica Sanchez: A Framework for Woman’s Health
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services